[Surgical treatment for hilar cholangiocarcinoma of Bismuth-Corlette type IV]
Yu He1, Zhi-hua Li, Jing-xiu Cai
1Institute of Hepatobiliary Surgery, Southwest Hospital, Third Military Medical University, Chongqing 400038, China.
Insights
Radical resection offers the best chance for cure in hilar cholangiocarcinoma (HCCA) of Bismuth-Corlette type IV. Surgical management and effective biliary drainage are crucial for improving survival and quality of life in these patients.
Area of Science:
- Hepatobiliary Surgery
- Surgical Oncology
- Gastroenterology
Context:
- Hilar cholangiocarcinoma (HCCA), specifically Bismuth-Corlette type IV, presents significant surgical challenges.
- Retrospective analysis of 73 HCCA patients treated between 2002 and 2008.
- Diagnosis confirmed via imaging and pathological examination.
Purpose:
- To investigate the surgical treatment outcomes for Bismuth-Corlette type IV hilar cholangiocarcinoma.
- Evaluate the efficacy of radical resection versus palliative or drainage procedures.
Summary:
- Radical resection was performed in 19 patients (26.0% resection rate).
- 1-year and 3-year survival rates for radical resection were 36.8% and 10.5%.
- Patients undergoing only drainage had a 1-year survival rate of 6.3%.
Impact:
- Radical resection is identified as the potentially curative treatment for HCCA.
- Appropriate use of internal and external biliary drainage can improve patient quality of life.
- Highlights the importance of surgical expertise in managing complex hilar cholangiocarcinoma cases.
Objective:
To investigate the surgical treatment for hilar cholangiocarcinoma(HCCA) of Bismuth-Corlette type IV.
Methods:
The clinical data of 73 HCCA patients admitted in Southwest Hospital, the Third Military Medical University from January 2002 to December 2008 were analyzed retrospectively. There were 41 males and 32 females, aged from 30 to 84 years old (averaged, 56.8 years old). All patients were diagnosed as hilar mass with hilar biliary obstruction by B-ultrasound, CT, magnetic resonance imaging, endoscopic retrograde cholangiopancreatography, magnetic resonance cholangiopancreatography or percutaneous transhepatic cholangiography, and confirmed by pathological examination in intra-operation and post-operation. Diagnosis of all patients were according to Bismuth-Corlette type IV.
Results:
Fifteen cases underwent percutaneous transhepatic cholangial drainage, stents were implanted in 8 patients. Simple internal drainage was performed on 25 of the 73 patients and 4 with palliative resection. Radical resection was performed on 19 patients. The radical resection rate of HCCA were 26.0%. The 1, 3 years of survival rates were 36.8%, 10.5% respectively. The 1 year survival rate was 6.3% in drainage group.
Conclusion:
Radical resection is the potentially curative treatment for HCCA, a sufficient, reasonable use of internal and external drainage would improve the patient's quality of life.